Media

Media

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY

May 2010

21

HRA Pharma's Partner Preglem Announces Positive Phase III Results for Ulipristal Acetate in the Treatment of Uterine Fibroids.

April 2010

27

HRA Pharma Announces FDA Advisory Committee Review of Ulipristal Acetate

April 2010

12

Preglem licenses additional rights for ulipristal acetate from HRA Pharm

Février 2010

16

HRA Pharma's NorLevo® Now the First Emergency Contraceptive Available Without a Prescription in Ireland.

Février 2010

11

HRA Pharma's new emergency contraceptive ellaOne® accepted by the Scottish Medicines Consortium.

Février 2010

01

Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S.

January 2010

29

Breaking News in Emergency Contraception: HRA Pharma Unveils Clinical Data on ellaOne®.

December 2009

18

HRA Pharma Expands to Spain and Launches ellaOne®.

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?